Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Diabetes Mellitus Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

36 recruiting trials for Diabetes Mellitus. Eligibility criteria explained in plain English.

TrialFinderData lists 36 Diabetes Mellitus clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Across the trials that carry a phase, Phase 1 is the largest group at 40% (2 studies); the largest phase groups are Phase 1: 2, Phase 2 / Phase 3: 1, Phase 4: 1, Phase 2: 1.

Research is led by Orbis (2), The University of Hong Kong (1), Memorial Sloan Kettering Cancer Center (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is Placebo (other, 2 trials), followed by Usual Care, COVID-19 outbreaks.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
36
Total Trials
36
Recruiting Now
0
Phase 3 Trials
10
Sponsors

Track Diabetes Mellitus trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT05248412

The Long-term Spill-over Impact of COVID-19 on Health and Healthcare of People With Non-communicable Diseases

Objectives and aim: To evaluate the long-term spill-over (indirect) effect of Coronavirus disease (COVID-19) on health outcomes and healthcare utilization among people with...

Sponsor: The University of Hong KongEnrolling: 2500001 location
RECRUITINGPhase 1NCT06623396

A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

Participants will have a sample of their white blood cells, called T cells, collected using a procedure called leukapheresis. The collected T cells will be sent to a laboratory at...

Sponsor: Memorial Sloan Kettering Cancer CenterEnrolling: 187 locations
RECRUITINGNCT07173062

Algae Effects in Markers of Cardiovascular Risk and Gut Microbiome

The Western diet, rich in fat and sugar, contributes to cardiovascular risk and alters the body metabolism, specifically through the modulation of the microbiome. Microbiome is...

Sponsor: Universidade do PortoEnrolling: 1501 location
RECRUITINGNCT06591780

Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy

This study aims to collect data to improve gait function in individuals with Diabetic Peripheral Neuropathy (DPN). The primary goals are to evaluate: * Biomechanical mechanisms...

Sponsor: Florida Institute for Human and Machine CognitionEnrolling: 251 location
RECRUITINGNCT03594344

Additional Hyperbaric Oxygen After Lower Extremity Amputation

This study evaluates the effect of additional hyperbaric oxygen therapy after lower extremity amputation. The patients will be randomized after amputation to either a treatment...

Sponsor: Oslo University HospitalEnrolling: 1202 locations
RECRUITINGNCT04210089

Total Contact Soft Cast in Diabetic Foot Ulcers

To determine the effectiveness, compliance, patient tolerance, ease of use and safety of total contact soft cast in diabetic foot ulcers.

Sponsor: University of MinnesotaEnrolling: 1001 location
RECRUITINGNCT06203106

NYSCF Scientific Discovery Biobank

The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate diverse disease research using cells from the body (such as skin or blood...

Sponsor: New York Stem Cell Foundation Research InstituteEnrolling: 100001 location
RECRUITINGNCT05759676

Efficacy and Safety of Polymer-free Amphilimus-eluting Stent According to the Diabetes

Drug-eluting stents (DES) have been found to reduce the rate of stent restenosis compared to bare metal stents (BMS), but the first generation DES caused an increase in stent...

Sponsor: Korea University Anam HospitalEnrolling: 18001 location
RECRUITINGNCT07512609

Environment, Inflammation and Metabolic Diseases Study

The aim is to establish an effective and practical early warning model for endocrine and metabolic diseases based on an environmental-gene-protein panoramic network, to uncover...

Sponsor: Qifu LiEnrolling: 80001 location
RECRUITINGNCT05476627

Risk Factors and Multiomics Study of Chronic Kidney Disease Caused by Metabolic Diseases

With the development of China's economy, people's living standard have improved, and the dietary structure have changed. Metabolic diseases, such as hypertension, diabetes,...

Sponsor: Peking Union Medical College HospitalEnrolling: 2001 location
RECRUITINGNCT06775028

Integrated Approach in Frail Older People with Atrial Fibrillation

The study will verify if a structured multidisciplinary approach (called iABC), aimed to improve the appropriate management of elderly AF patients with multimorbidity (the i-ABC...

Sponsor: Heart Care FoundationEnrolling: 125020 locations
RECRUITINGNCT03622359

Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease

The aim of this clinical study is to 1) establish a healthy database for nuclear perfusion imaging of the lower extremities and 2) assess the prognostic value of radiotracer-based...

Sponsor: Nationwide Children's HospitalEnrolling: 1921 location
RECRUITINGNCT03995238

Optimizing Gait Rehabilitation for Veterans With Non-traumatic Lower Limb Amputation

The population of older Veterans with non-traumatic lower limb amputation is growing. Following lower limb amputation, asymmetrical movements persist during walking and likely...

Sponsor: VA Office of Research and DevelopmentEnrolling: 542 locations
RECRUITINGNCT04014413

Safety and Efficacy of Fecal Microbiota Transplantation

The gut microbiota is critical to health and functions with a level of complexity comparable to that of an organ system. Dysbiosis, or alterations of this gut microbiota ecology,...

Sponsor: Chinese University of Hong KongEnrolling: 4501 location
RECRUITINGPhase 1NCT06731218

Phase I Clinical Study to Evaluate the Safety and Efficacy of RGB-5088 in Patients With Type 1 Diabetes Mellitus

This Phase I clinical trial is a single-center, single-arm, open-label study aimed at evaluating the safety and therapeutic efficacy of RGB-5088 islet cell transplantation in...

Sponsor: Hangzhou Reprogenix Bioscience, IncEnrolling: 101 location
RECRUITINGNCT07621419

Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of...

The goal of this prospective, multicenter, observational study is to evaluate the real-world effectiveness and safety of oral and subcutaneous semaglutide in adults with type 2...

Sponsor: Hospital Italiano de Buenos AiresEnrolling: 1452 locations
RECRUITINGNCT02841553

Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study

In this study, the investigators hypothesize that studying monogenic variants with strong effect associated with severe insulin deficiency of Wolfram syndrome will provide...

Sponsor: Washington University School of MedicineEnrolling: 50001 location
RECRUITINGNCT06764069

Feasibility Study to Evaluate an Intravascular Blood Continuous Glucose Sensor

The goal of this early first in man clinical trial is to evaluate the safety of an implantable continuous blood glucose monitoring system in participants with Diabetes Mellitus....

Sponsor: GlucotrackEnrolling: 101 location
RECRUITINGPhase 2 / Phase 3NCT06387199

Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous...

A closed-loop insulin system, often labelled the "artificial pancreas" (AP), consists of an insulin pump, a continuous glucose monitor, and an interface coordinating between them...

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health CentreEnrolling: 261 location
RECRUITINGNCT07135531

Continuous Glucose Monitoring (CGM) in an Underserved Population

The investigators aim is to conduct a randomized clinical trial in an underserved population who are either uninsured or on Medicaid and taking at least one injection of insulin...

Sponsor: Tulane UniversityEnrolling: 501 location
RECRUITINGNCT06107816

A Fruit and Vegetable Prescription Program

Dietary intake of fruits and vegetables (F\&V) is a cornerstone for the treatment of type 2 diabetes, however less than 16% of Hispanic adults consume the recommended number of...

Sponsor: Milton S. Hershey Medical CenterEnrolling: 1201 location
RECRUITINGNCT07420634

Multilevel Ecological and COM-B Determinants of Medication Adherence in Adults With Diabetes

This observational study aims to understand why some adults with diabetes find it difficult to take their medicines as prescribed. Medication adherence is essential for...

Sponsor: University of MalayaEnrolling: 2201 location
RECRUITINGNCT07448805

Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit

Researchers at the Department of Intensive Internal Medicine and the Department of Endocrinology and Diabetology will conduct a study to verify the accuracy and safety of the new...

Sponsor: University Medical Centre MariborEnrolling: 1001 location
RECRUITINGPhase 4NCT06132477

Impact GLP-1 Agonists Following Bariatric

Glucagon-like peptide 1 (GLP-1) is a hormone that helps regulate blood glucose levels through improved insulin sensitivity and release of insulin from the pancreas, control...

Sponsor: University of Missouri-ColumbiaEnrolling: 1501 location
RECRUITINGNCT06396871

Deep Phenotyping of Peripheral Blood Cells and Circulating Factors in Metabolic Diseases

The goal of this cross-sectional observational study is to to perform a thorough characterization of the quantitative and qualitative differences in peripheral blood cells, and...

Sponsor: Technische Universität DresdenEnrolling: 1801 location
RECRUITINGNCT05046483

Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMI

The aim of the prospective observational DISTEMI-Study in people with and without Diabetes mellitus (DI) after new onset of ST-Segment Elevation Myocardial Infarction (STEMI) aged...

Sponsor: German Diabetes CenterEnrolling: 3001 location
RECRUITINGNCT07339852

Implementation and Evaluation of a Pharmacist-led Diabetes Care Pathway in Alberta Community Pharmacies

As of 2024, nine percent of Albertans are living with Type 2 diabetes, which increases their risk for cardiovascular disease, stroke, blindness, and kidney failure. Unfortunately,...

Sponsor: University of AlbertaEnrolling: 6001 location
RECRUITINGNCT06615609

"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft...

This study aims to evaluate the effect of an AI-assisted "Smart family doctor" digital health management tool on improving the control rates of hypertension, diabetes, and...

Sponsor: China National Center for Cardiovascular DiseasesEnrolling: 5361 location
RECRUITINGNCT06694012

Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

The aim of this study is to investigate the relationship between body fat distribution measured by CT scan and related risk factors with the risk of incident metabolic and...

Sponsor: Osaka Metropolitan UniversityEnrolling: 20001 location
RECRUITINGNCT06955611

Is Community Based Monitoring of Diabetic Maculopathy and Pre-proliferative Diabetic Retinopathy Safe?

To assess a pathway using opticians based in their practices and a 'virtual' review by a consultant ophthalmologist, based in the hospital to assess suspected diabetic...

Sponsor: Hywel Dda Health BoardEnrolling: 1501 location
RECRUITINGPhase 2NCT04547439

Sleep, Diabetic Retinopathy and Melatonin

This study explores the use of melatonin in patients with diabetic retinopathy

Sponsor: University of Illinois at ChicagoEnrolling: 421 location
RECRUITINGNCT05704491

AI Screening for Diabetic Retinopathy

The increasing prevalence of diabetes mellitus represents a major health problem, especially since around 40% of diabetic patients develop diabetic retinopathy, which severely...

Sponsor: West German Center of Diabetes and HealthEnrolling: 1001 location
RECRUITINGNCT06124586

Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)

The planned study is a Randomized Controlled Monocentric Trial, which will provide evidence on whether early angiography in percutaneous transluminal angioplasty (PTA) readiness...

Sponsor: Heinrich-Heine University, DuesseldorfEnrolling: 2001 location
RECRUITINGNCT06467903

Evaluation Conducted to Capture Patients With Diabetic Retinopathy in General Practitioners, Using SW as Medical Device

A prospective, comparative multicenter evaluation conducted to capture patients with diabetic retinopathy in general practitioners, using AI medical device

Sponsor: Bonmedix Holding a.s.Enrolling: 10001 location
RECRUITINGNCT06968611

Improving Patient-centered Care for Diabetes in Bangladesh Through "Dynamic Integration" of Vision Care on the Demand...

The goal of this clinical trial is to determine whether there is an increase in participant uptake of diabetes mellitus (DM) and diabetic retinopathy (DR) services and improved...

Sponsor: OrbisEnrolling: 6402 locations
RECRUITINGNCT06968637

Improving Patient-centered Care for Diabetes in Bangladesh Through "Dynamic Integration" of Vision Care on the Supply...

The goal of this clinical trial is to determine whether integration of vision care into the DM treatment system, by providing specific recommendations to doctors for management of...

Sponsor: OrbisEnrolling: 3362 locations

Frequently Asked Questions

There are currently 36 clinical trials for Diabetes Mellitus, with 36 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Diabetes Mellitus, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Diabetes Mellitus, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.